By Josh White
Date: Friday 09 May 2025
(Sharecast News) - Oxford BioDynamics announced on Friday that its Oxford-based laboratory had been accredited by the UK Accreditation Service (UKAS) as a clinical facility under ISO 15189, enabling it to process 'EpiSwitch' clinical tests in the UK.
By Josh White
Date: Wednesday 12 Feb 2025
(Sharecast News) - Oxford BioDynamics announced on Wednesday that it has signed a distribution agreement with Regina Maria, Romania's largest private healthcare provider, to offer its EpiSwitch PSE and CiRT blood tests to physicians and patients across the country.
By Josh White
Date: Wednesday 05 Feb 2025
(Sharecast News) - Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting colorectal cancer and precancerous polyps using a blood sample.
Currency | UK Pounds |
Share Price | 0.26p |
Change Today | 0.005p |
% Change | 1.96 % |
52 Week High | 8.13 |
52 Week Low | 0.25 |
Volume | 12,462,967 |
Shares Issued | 1,957.58m |
Market Cap | £5.09m |
Value | ![]() |
---|
Price Trend | ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 80,000 @ 0.26p |
16:11 | 194,174 @ 0.26p |
16:07 | 9,785 @ 0.26p |
15:49 | 200,000 @ 0.25p |
15:37 | 4,703 @ 0.27p |
You are here: research